IL-1 acts on T cells to enhance the magnitude of in vivo immune responses
Authors:
- Stephane CaucheteuxSCStephane Caucheteux
- Michelle CrankMCMichelle Crank
- Jane Hu-LiJHJane Hu-Li
- William E. PaulWPWilliam E. Paul
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Regulating human Th17 cells via differential expression of IL-1 receptorBlood, 2010
- The Receptor SIGIRR Suppresses Th17 Cell Proliferation via Inhibition of the Interleukin-1 Receptor Pathway and mTOR Kinase ActivationImmunity, 2010
- IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cellsProceedings of the National Academy of Sciences, 2009
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiationProceedings of the National Academy of Sciences, 2009
- Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 SignalingImmunity, 2009
- IL-6 Increases Primed Cell Expansion and SurvivalThe Journal of Immunology, 2005
- IL‐1 acts on antigen‐presenting cells to enhance the in vivo proliferation of antigen‐stimulated naive CD4 T cells via a CD28‐dependent mechanism that does not involve increased expression of CD28 ligandsEuropean Journal of Immunology, 2004
- IL-6 is an intermediate in IL-1-induced thymocyte proliferation.The Journal of Immunology, 1989
- Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors.1979
- POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENSJournal of Experimental Medicine, 1972